Neumora Therapeutics NMRA
NASDAQ NMRA
$0.60 -0.08 (-11.76%)
At close: Sep 30, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Long-Term Investments (2022 - 2024)

Updated

Neumora Therapeutics' Long-Term Investments came in at $302,000 for Q1 2024, down 96.9% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Long-Term Investments (2022 - 2024) Analysis & Trends

At the end of FY2023, Neumora Therapeutics' Long-Term Investments was $9.85 million, down 58.1% from FY2022.

  • Going back by year, Long-Term Investments was $23.51 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Neumora Therapeutics 112.74 Mn 112.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 302,000.00
Dec 31, 2023 9.85 Mn
Sep 30, 2023 9.91 Mn
Dec 31, 2022 23.51 Mn
API Access

Neumora Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=NMRA&period=max&api_key=YOUR_API_KEY